抑癌基因PML在宫颈病变组织中的突变探讨

何志晖, 李清秀, 王莉, 谭佩婵

何志晖, 李清秀, 王莉, 谭佩婵. 抑癌基因PML在宫颈病变组织中的突变探讨[J]. 实用临床医药杂志, 2011, (11): 77-79. DOI: 10.3969/j.issn.1672-2353.2011.11.025
引用本文: 何志晖, 李清秀, 王莉, 谭佩婵. 抑癌基因PML在宫颈病变组织中的突变探讨[J]. 实用临床医药杂志, 2011, (11): 77-79. DOI: 10.3969/j.issn.1672-2353.2011.11.025
HE Zhi-hui, LI Qing-xiu, WANG li, TAN Pei-chan. A study of tumor suppressor gene PML mutation in cervical lesions[J]. Journal of Clinical Medicine in Practice, 2011, (11): 77-79. DOI: 10.3969/j.issn.1672-2353.2011.11.025
Citation: HE Zhi-hui, LI Qing-xiu, WANG li, TAN Pei-chan. A study of tumor suppressor gene PML mutation in cervical lesions[J]. Journal of Clinical Medicine in Practice, 2011, (11): 77-79. DOI: 10.3969/j.issn.1672-2353.2011.11.025

抑癌基因PML在宫颈病变组织中的突变探讨

详细信息
  • 中图分类号: R711.74

A study of tumor suppressor gene PML mutation in cervical lesions

  • 摘要: 目的 探讨抑癌基因早幼粒细胞性白血病基因(PML)在宫颈病变组织中是否存在突变.方法 随机选取以下宫颈病变新鲜组织标本,包括宫颈上皮内瘤样病变I级(CIN Ⅰ)、CIN Ⅱ、CIN Ⅲ、宫颈浸润鳞癌各30例、以及因其他疾病切除子宫病理证实为慢性宫颈炎者30例.用变性高效液相色谱(DHPLC)进行PML基因全部外显子及内含子-外显子交接区突变的筛查,对其中10例宫颈浸润鳞癌组织进行PML基因全部外显子及内含子-外显子交接区测序.结果 全部组织均未发现PML基因突变.结论 PML在蛋白质水平的表达改变不是由其基因突变所引起.
  • Vizcaino A P, Moreno V, Bosch F X. InternationaL trends incidence of cervicaL cancer:SquamousceLL carcinoma [J]. International Journal of Cancer, 2002, (86):429.
    Einstein M H, GoLdberg G L. Human papiLLomavirus and cervicaL neopLasia [J]. Cancer Investigation, 2002, (7/8):1080.doi: 10.1081/CNV-120005927.
    Munoz N, Bosch F X, DeSanjose S. EpidemioLogic cLassification of human papiLLomavirus typesassociated with cervicaL cancer [J]. the New England Journal of Medicine, 2003, (6):489.doi: 10.1056/NEJMoa021641.
    Lars C H, Georgios R. FamiLiaL cancer history in patients with carcinoma of the cervix uteri [J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2002, (1):54.doi: 10.1016/S0301-2115(01)00520-6.
    Zhong S, SaLomoni P, PamdoLfi P P. The transcriptionaL roLe of PML and the nucLear body [J]. Nature Cell Biology, 2000, (5):E85.
    SaLomoni P, PandoLfi P P. The roLe of PML in tumor suppression [J]. Cell, 2002.165.doi: 10.1016/S0092-8674(02)00626-8.
    Gurrieri C, Capodieci P, Bernardi R. Loss of the tumor suppressor PML in human cancers of muLtipLe histoLogic origins [J]. Journal of the National Caneer Institute, 2004(4):269.doi: 10.1093/jnci/djh043.
    Gambacorta M, FLenghi L, FagioLi M. Heterogeneous nucLear expression of the promyeLocyticLeukemia(PML) protein in normaL and neopLastic human tissues [J]. Amercian Journal of Pathology, 1996.2023.
    Szendefi M, WaLt H, Krasieva T B. Association between promyeLocyte protein and smaLLubiquitin-Like modifier protein and the progression of cervicaL [Z].
计量
  • 文章访问数:  115
  • HTML全文浏览量:  39
  • PDF下载量:  7
  • 被引次数: 0
出版历程
  • 发布日期:  2011-09-29

目录

    /

    返回文章
    返回
    x 关闭 永久关闭